new publications 2023 Q1

11.04.2023

Please find below a list of selected MSC-related publications from Jan-Mar 2023:

 

Red blood cell transfusion-related eicosanoid profiles in intensive care patients-A prospective, observational feasibility study.
Raeven P, Hagn G, Niederstaetter L, Brugger J, Bayer-Blauensteiner S, Domenig C, Hoetzenecker K, Posch M, Leitner G, Gerner C, Baron DM.
Front Physiol. 2023 Mar 16;14:1164926. doi: 10.3389/fphys.2023.1164926. eCollection 2023.

Results of the Austrian Children's Biomonitoring Survey 2020 part A: Per- and polyfluorinated alkylated substances, bisphenols, parabens and other xenobiotics.
Hartmann C, Jamnik T, Weiss S, Göß M, Fareed Y, Satrapa V, Braun D, Flasch M, Warth B, Uhl M.
Int J Hyg Environ Health. 2023 Apr;249:114123. doi: 10.1016/j.ijheh.2023.114123. Epub 2023 Feb 3.

Secondary Metabolite Production Potential in a Microbiome of the Freshwater Sponge Spongilla lacustris.
Graffius S, Garzón JFG, Zehl M, Pjevac P, Kirkegaard R, Flieder M, Loy A, Rattei T, Ostrovsky A, Zotchev SB.
Microbiol Spectr. 2023 Feb 2:e0435322. doi: 10.1128/spectrum.04353-22. Online ahead of print.

A platinum(IV) prodrug strategy to overcome glutathione-based oxaliplatin resistance.
Fronik P, Gutmann M, Vician P, Stojanovic M, Kastner A, Heffeter P, Pirker C, Keppler BK, Berger W, Kowol CR.
Commun Chem. 2022 Apr 6;5(1):46. doi: 10.1038/s42004-022-00661-z.

Methods to identify protein targets of metal-based drugs.
Skos L, Borutzki Y, Gerner C, Meier-Menches SM.
Curr Opin Chem Biol. 2023 Apr;73:102257. doi: 10.1016/j.cbpa.2022.102257. Epub 2023 Jan 2.